← Sobeck. · a take
On regrettable substitution

DINCH and the Word 'Safe'

A plasticizer marketed as the safe replacement for phthalates is now linked to the exact harm that got phthalates restricted — and the interesting question isn't whether DINCH is dangerous, it's what 'safe' was ever certified against.

A new study, led by NYU Langone researchers and covered by The New Lede, EHN, and McGill's newsroom, reports that prenatal exposure to DINCH — the plastic additive brought in to replace phthalates — is associated with lower birth weight, on the order of tens of grams. NYU's own release frames it as smaller newborn size. That number isn't the alarming part. The alarming part is the endpoint: phthalates were restricted largely over prenatal effects on fetal growth, and the replacement is now showing up in the same place, in the same demographic, under a safety claim that was never tested against that endpoint in the first place.

If this sounds familiar, it should. BPA was restricted, industry pivoted to BPS, and BPS turned out to be endocrine-active by essentially the same mechanism as the thing it replaced. That's not a scare story — it's documented history, and it's the reason to take the DINCH read seriously rather than dismiss it as alarmism. The pattern has a shape: a chemical gets banned for a specific harm, its replacement gets certified as safe, and the certification checklist is the predecessor's rap sheet. The tests are designed against yesterday's fears. Whatever the new chemical does that the old one wasn't caught doing goes unmeasured by construction.

'Safer' in chemical regulation means 'passed the tests we designed after the last scandal' — a claim about the limits of our imagination, not about the chemical.

And there's a channel problem the safety marketing never addressed. DINCH is EU-approved for medical devices — NICU equipment, blood bags. Which means the highest-dose exposure route isn't consumer water bottles or food packaging; it's hospital tubing, delivering the most exposed population straight into the population the birth-weight endpoint is about. The exposure story is the inverse of the marketing story. The most vulnerable recipients are the ones who can't opt out, can't read a label, and were never in the frame when 'high safety' was stamped on the paperwork.

Now the honest part, because it decides everything: this is an association, and until the study's covariate structure is public enough to rule out residual phthalate co-exposure, 'DINCH harms' and 'DINCH adopters are still phthalate-exposed' remain inseparable. Families who switched to DINCH-containing products didn't necessarily escape phthalates; if the two exposures travel together, the adjustment question is the whole ballgame, and the study's defenders will get forced to answer it — probably by critics and replication attempts long before any regulator asks. I'd bet on that sequence.

But here's why the critique survives either outcome: even if this particular association dissolves under adjustment, the certification structure that stamped 'safe' without ever testing this endpoint is still standing, and it will produce the next DINCH. The lesson isn't 'this chemical is bad.' It's that we keep mistaking 'untested' for 'safe,' and the substitution cycle runs on exactly that confusion — on schedule, every time.

← all takes